A216400 Stock Overview
Invites Biocore Co., Ltd. provides bioanalytical and central lab services in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Invites Biocore Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩8,930.00 |
52 Week High | ₩11,990.00 |
52 Week Low | ₩7,500.00 |
Beta | 0 |
1 Month Change | -1.33% |
3 Month Change | -1.11% |
1 Year Change | 11.63% |
3 Year Change | -34.58% |
5 Year Change | 28.49% |
Change since IPO | -9.80% |
Recent News & Updates
Recent updates
Shareholder Returns
A216400 | KR Life Sciences | KR Market | |
---|---|---|---|
7D | -2.2% | -1.5% | 2.1% |
1Y | 11.6% | 7.8% | 13.4% |
Return vs Industry: A216400 exceeded the KR Life Sciences industry which returned 7.5% over the past year.
Return vs Market: A216400 underperformed the KR Market which returned 13.4% over the past year.
Price Volatility
A216400 volatility | |
---|---|
A216400 Average Weekly Movement | 1.8% |
Life Sciences Industry Average Movement | 7.3% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A216400 has not had significant price volatility in the past 3 months.
Volatility Over Time: A216400's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | n/a | Hyung-Sik Choi | https://www.bio-core.com |
Invites Biocore Co., Ltd. provides bioanalytical and central lab services in South Korea and internationally. It offers bioanalytical testing service during biological equivalence tests, clinical trials, toxicokinetics, nonclinical trials, vivo dynamic analysis, comparative dissolution test, and biomarker analysis; provides project strategic planning, medical translation, clinical research, quality assurance, monitoring, and data management for clinical services; and offers services, such as pharmaceutical quality control testing, emergency testing for food and drug safety, impurity testing, testing for licensed pharmaceutical products, and pharmaceutical stability testing. The company also provides disease susceptibility and anticancer drug susceptibility test; personalized genetic testing services, chromosomal microarray analysis, newborn screening, diagnostic exome sequencing, and non-invasive prenatal testing; and sequencing, microarray analysis, Real-Time PCR analysis services.
Invites Biocore Co., Ltd. Fundamentals Summary
A216400 fundamental statistics | |
---|---|
Market cap | ₩68.86b |
Earnings (TTM) | ₩0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A216400 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A216400 income statement (TTM) | |
---|---|
Revenue | ₩0 |
Cost of Revenue | ₩0 |
Gross Profit | ₩0 |
Other Expenses | ₩0 |
Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did A216400 perform over the long term?
See historical performance and comparison